Final Determinations issued by the Borderline Section (Medicines) UK

Main Category: Public Health
Article Date: 14 Jun 2004 - 16:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

This section of the site gives details of Final Determinations made in accordance with Regulation 3(1) of the Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 or Regulation 3a of the Medicines for Human Use (Marketing Authorisations etc.) Regulations 1994 as amended.

Final Determinations are issued by the Borderline Section of the MHRA on behalf of the Licensing Authority of the United Kingdom. It should be noted that determinations are made on the basis of the product status at the time it was investigated. Many products will continue to be marketed in the UK having made appropriate modifications to ingredients and/or product presentation, to bring them into line with the Regulations.

Final Determinations issued by the Borderline Section

Final Determinations issued by the Borderline Section - Volume 2 (January - June 2004)

Final Determinations issued by the Borderline Section - Volume 1 (March 2000 - December 2003)

Contact for further information

For further information on this part of our site, please contact our Borderline Section, 16-1, MHRA, Market Towers, 1 Nine Elms Lane, London SW8 5NQ, telephone 020-7084 2759, fax 020-7084 2439 or e-mail info@mhra.gsi.gov.uk

what is a medicine/borderline...?

Medicines and Healthcare products Regulatory Agency, UK